Filtros de búsqueda

Lista de obras de

Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2).

artículo científico publicado en 2018

Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma.

artículo científico publicado en 2018

Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot Study

scientific article published on 09 March 2019

Durable clinical benefit in metastatic renal cell carcinoma patients who discontinue PD-1/PD-L1 therapy for immune-related adverse events (irAEs).

artículo científico publicado en 2018

Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma

scientific article published on 24 September 2019

Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma

scientific article published on 17 September 2018

First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience.

artículo científico publicado en 2017

Immunotherapy in the Elderly

artículo científico publicado en 2017

JAVELIN: avelumab another spear to fight urothelial carcinoma.

artículo científico publicado en 2017

Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma

scientific article published on 01 June 2019

Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019

artículo científico publicado en 2019

Manifestations of Von Hippel Lindau syndrome: a retrospective national review.

artículo científico

Metabolomic adaptations and correlates of survival to immune checkpoint blockade

scientific article published on 25 September 2019

Pan-urologic cancer genomic subtypes that transcend tissue of origin

artículo científico publicado en 2017

Proton Pump Inhibitors and Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma.

artículo científico publicado en 2017

Response of Primary Renal Cell Carcinoma to Systemic Therapy

scientific article published on 06 October 2019

Response to single agent PD-1 inhibitor after progression on previous PD-1/PD-L1 inhibitors: a case series.

artículo científico publicado en 2017

State of the Future: Translational Approaches in Renal Cell Carcinoma in the Immunotherapy Era

artículo científico publicado en 2019

Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions

article

Systemic treatments for metastatic urothelial carcinoma

article

Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinoma

artículo científico publicado en 2018

The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma

artículo científico publicado en 2018

Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non-Lymph Node Distant Metastasis.

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda